PML bodies provide an important platform for the maintenance of telomeric chromatin integrity in embryonic stem cells

被引:58
作者
Chang, Fiona T. M. [1 ]
McGhie, James D. [1 ]
Chan, F. Lyn [1 ]
Tang, Michelle C. [2 ]
Anderson, Melissa A. [2 ]
Mann, Jeffrey R. [2 ]
Choo, K. H. Andy [2 ]
Wong, Lee H. [1 ]
机构
[1] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia
[2] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Paediat, Parkville, Vic 3052, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
PROMYELOCYTIC LEUKEMIA BODIES; NUCLEAR-BODIES; HISTONE CHAPERONE; ATRX; DAXX; PROTEIN; MUTATIONS; LENGTH; H3.3; HETEROCHROMATIN;
D O I
10.1093/nar/gkt114
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously shown that alpha-thalassemia mental retardation X-linked (ATRX) and histone H3.3 are key regulators of telomeric chromatin in mouse embryonic stem cells. The function of ATRX and H3.3 in the maintenance of telomere chromatin integrity is further demonstrated by recent studies that show the strong association of ATRX/H3.3 mutations with alternative lengthening of telomeres in telomerase-negative human cancer cells. Here, we demonstrate that ATRX and H3.3 co-localize with the telomeric DNA and associated proteins within the promyelocytic leukemia (PML) bodies in mouse ES cells. The assembly of these telomere-associated PML bodies is most prominent at S phase. RNA interference (RNAi)-mediated knockdown of PML expression induces the disassembly of these nuclear bodies and a telomere dysfunction phenotype in mouse ES cells. Loss of function of PML bodies in mouse ES cells also disrupts binding of ATRX/H3.3 and proper establishment of histone methylation pattern at the telomere. Our study demonstrates that PML bodies act as epigenetic regulators by serving as platforms for the assembly of the telomeric chromatin to ensure a faithful inheritance of epigenetic information at the telomere.
引用
收藏
页码:4447 / 4458
页数:12
相关论文
共 56 条
[21]   Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic Regions [J].
Goldberg, Aaron D. ;
Banaszynski, Laura A. ;
Noh, Kyung-Min ;
Lewis, Peter W. ;
Elsaesser, Simon J. ;
Stadler, Sonja ;
Dewell, Scott ;
Law, Martin ;
Guo, Xingyi ;
Li, Xuan ;
Wen, Duancheng ;
Chapgier, Ariane ;
DeKelver, Russell C. ;
Miller, Jeffrey C. ;
Lee, Ya-Li ;
Boydston, Elizabeth A. ;
Holmes, Michael C. ;
Gregory, Philip D. ;
Greally, John M. ;
Rafii, Shahin ;
Yang, Chingwen ;
Scambler, Peter J. ;
Garrick, David ;
Gibbons, Richard J. ;
Higgs, Douglas R. ;
Cristea, Ileana M. ;
Urnov, Fyodor D. ;
Zheng, Deyou ;
Allis, C. David .
CELL, 2010, 140 (05) :678-691
[22]   DNA methyltransferases control telomere length and telomere recombination in mammalian cells [J].
Gonzalo, S ;
Jaco, I ;
Fraga, MF ;
Chen, TP ;
Li, E ;
Esteller, M ;
Blasco, MA .
NATURE CELL BIOLOGY, 2006, 8 (04) :416-U66
[23]   Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme [J].
Hakin-Smith, V ;
Jellinek, DA ;
Levy, D ;
Carroll, T ;
Teo, M ;
Timperley, WR ;
McKay, MJ ;
Reddel, RR ;
Royds, JA .
LANCET, 2003, 361 (9360) :836-838
[24]   The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome [J].
Hansen, RS ;
Wijmenga, C ;
Luo, P ;
Stanek, AM ;
Canfield, TK ;
Weemaes, CMR ;
Gartler, SM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (25) :14412-14417
[25]   Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes [J].
Heaphy, Christopher M. ;
Subhawong, Andrea P. ;
Hong, Seung-Mo ;
Goggins, Michael G. ;
Montgomery, Elizabeth A. ;
Gabrielson, Edward ;
Netto, George J. ;
Epstein, Jonathan I. ;
Lotan, Tamara L. ;
Westra, William H. ;
Shih, Le-Ming ;
Iacobuzio-Donahue, Christine A. ;
Maitra, Anirban ;
Li, Qing K. ;
Eberhart, Charles G. ;
Taube, Janis M. ;
Rakheja, Dinesh ;
Kurman, Robert J. ;
Wu, T. C. ;
Roden, Richard B. ;
Argani, Pedram ;
De Marzo, Angelo M. ;
Terracciano, Luigi ;
Torbenson, Michael ;
Meeker, Alan K. .
AMERICAN JOURNAL OF PATHOLOGY, 2011, 179 (04) :1608-1615
[26]   Altered Telomeres in Tumors with ATRX and DAXX Mutations [J].
Heaphy, Christopher M. ;
de Wilde, Roeland F. ;
Jiao, Yuchen ;
Klein, Alison P. ;
Edil, Barish H. ;
Shi, Chanjuan ;
Bettegowda, Chetan ;
Rodriguez, Fausto J. ;
Eberhart, Charles G. ;
Hebbar, Sachidanand ;
Offerhaus, G. Johan ;
McLendon, Roger ;
Rasheed, B. Ahmed ;
He, Yiping ;
Yan, Hai ;
Bigner, Darell D. ;
Oba-Shinjo, Sueli Mieko ;
Marie, Suely Kazue Nagahashi ;
Riggins, Gregory J. ;
Kinzler, Kenneth W. ;
Vogelstein, Bert ;
Hruban, Ralph H. ;
Maitra, Anirban ;
Papadopoulos, Nickolas ;
Meeker, Alan K. .
SCIENCE, 2011, 333 (6041) :425-425
[27]  
Henson JD, 2005, CLIN CANCER RES, V11, P217
[28]   DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity [J].
Henson, Jeremy D. ;
Cao, Ying ;
Huschtscha, Lily I. ;
Chang, Andy C. ;
Au, Amy Y. M. ;
Pickett, Hilda A. ;
Reddel, Roger R. .
NATURE BIOTECHNOLOGY, 2009, 27 (12) :1181-U148
[29]   POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end [J].
Hockemeyer, D ;
Sfeir, AJ ;
Shay, JW ;
Wright, WE ;
de Lange, T .
EMBO JOURNAL, 2005, 24 (14) :2667-2678
[30]   Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX [J].
Ishov, AM ;
Vladimirova, OV ;
Maul, GG .
JOURNAL OF CELL SCIENCE, 2004, 117 (17) :3807-3820